Estrella Immunopharma Inc.
Organization details
- Legal name
- Estrella Immunopharma Inc.
- Former names
- TradeUP Acquisition Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- Emeryville
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ESLA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001844417
- EIN
- 86-1314502
Board of directors
-
Cheng Liu · Director · CEOSince 2023
-
Cynthia Pussinen · Director · Chief Executive OfficerSince 2026
-
Dengyao Jia · DirectorSince 2025
-
Fan Wu · DirectorSince 2023
-
Hong Zhang · DirectorSince 2024
-
Marsha Roberts · DirectorSince 2023
-
Pei Xu · DirectorSince 2023
-
Xuejun Janelle Wu · DirectorSince 2023
Chief executives
Board connections
2 of this board's directors also sit on 2 other boards.
- via Dengyao Jia
- via Pei Xu
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 25, 2026 | Cheng Liu Director, Officer (CEO) | Option exercise | +100,000 | $0.82 | $82,000 |
| Aug 18, 2026 | Xu Jiandong Officer (Chief Financial Officer) | Option exercise | +100,000 | $0.82 | $82,000 |
| Oct 7, 2025 | Xu Jiandong Officer (Chief Financial Officer) | Open-market purchase | +1,000 | $1.33 | $1,330 |
| Sep 22, 2025 | Xu Jiandong Officer (Chief Financial Officer) | Open-market purchase | +1,000 | $1.16 | $1,160 |
| Sep 11, 2025 | Xu Jiandong Officer (Chief Financial Officer) | Open-market purchase | +100 | $1.04 | $104 |
| Sep 29, 2023 | Jeffrey A. Altman 10% owner | Other | −255,000 | $10.86 | $2,769,300 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Estrella Immunopharma Inc.
Who is the CEO of Estrella Immunopharma Inc.?
Cynthia Pussinen has been Estrella Immunopharma Inc.'s CEO since October 2026.
How many directors are on Estrella Immunopharma Inc.'s board?
Estrella Immunopharma Inc.'s board has 8 directors: Cheng Liu, Cynthia Pussinen, Dengyao Jia, Fan Wu, Hong Zhang, Marsha Roberts, Pei Xu and Xuejun Janelle Wu.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="estrella-immunopharma-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.